glp-1 digital health platform startups Technologies enabling long-term outcomes for users Beyond the Hype: Where and

Jorsal A, Kistorp C, Holmager P, Tougaard RS, Nielsen R, Hnselmann A, et al

Wright AK, Carr MJ, Kontopantelis E, Leelarathna L, Thabit H, Emsley R, et al

Based on the Route of Administration , Parenteral (injectable) medications represented the leading segment of the market in 2025 based on its proven efficacy and wide use in the treatment of obesity

JACC 82(9):833955 Rangaswami J, Bhalla V, de Boer IH, Staruschenko A, Sharp JA, Singh RR et al (2020) Cardiorenal protection with the newer antidiabetic agents in patients with diabetes and chronic kidney disease: a scientific statement from the American Heart Association

Klinic will offer retatrutide prescriptions once the medication is approved, and we will facilitate availability through trusted pharmacy partners